NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
'Everyone Is Geared Up For The Game': Team India's Fielding Coach T. Dilip Reflects On Super 4 Clash Against Pakistan At Asia Cup 2025; Video
Rural Maharashtra Sees Spike In 'Crypto-Christianity' Cases; Alleged Conversions Fuel Communal Tensions
Maharashtra Urdu Sahitya Academy Anniversary Row: Govt Allocates ₹1.2 Crore Against Promised ₹50 Crore
ED Arrests Suspended Bank Of India Officer In ₹16.10-Crore Fraud Case
